Agree that use as a supporting sling or structure is just an unproven theoretical possibility - great if it works but more than a few hurdles to be over come yet.
This agreement gives PNV $100k now, $350k on completion of clinical studies and CE product (how many years would be reasonable to complete this work?) and then $750k if a FDA approved product is developed (percentage chance of succeeding ??? less than 50%) with royalties after that. So the total milestone payments, all going perfectly well, equate to less than 0.4% of the current market capitalisation.
This is not the main game and PNV will sink or swim on its BTM and the take up by surgeons in the next few years.
PNV EL announcement today!, page-20
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.06 |
Change
0.000(0.00%) |
Mkt cap ! $1.422B | |||
| Open | High | Low | Value | Volume |
| $2.07 | $2.08 | $2.04 | $1.857M | 901.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 11510 | $2.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 76972 | 9 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |